about
Beta 3-adrenoreceptor regulation of nitric oxide in the cardiovascular system.Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification.Stimulation of beta(3)-adrenoceptors causes phosphorylation of p38 mitogen-activated protein kinase via a stimulatory G protein-dependent pathway in 3T3-L1 adipocytes.Pharmacogenomics of cardiovascular complications in diabetes and obesity.The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes.The emerging pharmacogenomics of the beta-adrenergic receptors.The internal anal sphincter: regulation of smooth muscle tone and relaxation.Compartmentalization of beta-adrenergic signals in cardiomyocytes.Stress and cardiac beta adrenoceptors.New perspectives on the role of autonomic nervous system in the genesis of arrhythmias.Adrenergic and calcium modulation of the heart in stress: from molecular biology to function.Role of adenylyl cyclase in reduced β-adrenoceptor-mediated vasorelaxation during maturation.β3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failureThe role of the autonomic nervous system in sudden cardiac death.β3 -AR and the vertebrate heart: a comparative view.Cardiac salvage by tweaking with beta-3-adrenergic receptors.Targeting β3-Adrenergic Receptors in the Heart: Selective Agonism and β-Blockade.New and Emerging Therapies and Targets: Beta-3 Agonists.Adrenergic regulation of vascular smooth muscle tone in calf digital artery.Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway.Antiarrhythmic effects of beta3-adrenergic receptor stimulation in a canine model of ventricular tachycardia.Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor.Role of nitric oxide in beta3-adrenoceptor activation on basal tone of internal anal sphincter.Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure.NO production and eNOS phosphorylation induced by epinephrine through the activation of beta-adrenoceptors.Roles of PKA, PI3K, and cPLA2 in the NO-mediated negative inotropic effect of beta2-adrenoceptor agonists in guinea pig right papillary muscles.A search for presynaptic beta3-adrenoceptors in the rat.Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value.SR59230A, a beta-3 adrenoceptor antagonist, inhibits ultradian brown adipose tissue thermogenesis and interrupts associated episodic brain and body heating.Functional β2-adrenoceptors in rat left atria: effect of foot-shock stress.5'-AMP-activated protein kinase is inactivated by adrenergic signalling in adult cardiac myocytes.
P2860
Q33838174-6F86A7B4-691C-48C1-99AD-AA17485B60D1Q34396286-2F469DFB-2683-489E-86B8-F3B846B5371DQ34637468-A5A853F0-8883-4757-819C-2811FC3A9033Q35044137-175B4699-86CC-4204-B5BB-A869A0996E97Q35647167-F57220A9-0155-4CEC-99D9-92F1067618CCQ35978071-62E5649F-2ABC-4CE6-B898-740788140130Q35980603-95E9F829-EEFB-45F6-8484-E40BEFF3646CQ36100751-15022774-9B95-4491-924B-4C285D81B007Q36384788-C301A8E4-AD4E-48A0-AB59-B004417581DCQ36559968-9CB2B72E-D033-40A9-8DC3-F30D8AF5E615Q36566820-3801CB79-1102-4BA9-9B17-215A19441C00Q36827279-61C00E08-3672-43C3-9AC4-528AEB13DC87Q37088360-E6684136-A171-409C-B2B0-3BE4977A25E7Q37142802-1A249E57-6420-49BF-AEA7-80356B148E16Q37161633-A17C8C86-203D-40E4-AA1F-DB8F34BFA86EQ38391176-1F92F755-B2C9-4E5E-93BA-2E79EAFD8BCDQ38784206-25B33639-B298-49A0-8C4A-D11172CEC9B6Q38974127-5AC01DF5-E5CA-4B82-95BE-4A116FFB4B6EQ39062830-1BC7682E-B0DA-4D84-B441-3034B4CAE2DFQ39691969-D216DCA8-23FD-447E-935E-0C59DB26C7C6Q41350928-C17D9750-8E52-4A2E-8428-161B51CFA6A7Q41881622-BE703A67-7572-4126-BD49-8FBD90A21AD0Q41948628-606ADD21-6E69-4C03-8D8C-269E9688AE86Q43982825-628A7638-317A-495D-8DF5-34E7CE958B1DQ44433197-6897F0E9-73FC-4702-9BC5-97A71ED20C8BQ44764133-6A5CE1AF-6C31-45E7-BA91-EA21CEBDB377Q46017515-22DBBF29-7DBB-4DAC-8582-73D1F8FCB3A4Q46264487-E5925776-6231-41A3-8E29-0A7460171DE0Q46422418-44F24A74-7C6B-435C-8068-432AA2453268Q47673235-E617541D-FD84-45E8-8058-AE51A2C38160Q48965095-F4F73DD1-AFDE-4AD0-A499-FD4A8CF74FE6Q51825605-DBB4CC52-C8C0-414D-A121-3B20A5FA8E18Q53225075-60EE5A89-A674-4210-A47C-4A24E46B259E
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Beta3-adrenoceptors in the cardiovascular system.
@ast
Beta3-adrenoceptors in the cardiovascular system.
@en
Beta3-adrenoceptors in the cardiovascular system.
@nl
type
label
Beta3-adrenoceptors in the cardiovascular system.
@ast
Beta3-adrenoceptors in the cardiovascular system.
@en
Beta3-adrenoceptors in the cardiovascular system.
@nl
prefLabel
Beta3-adrenoceptors in the cardiovascular system.
@ast
Beta3-adrenoceptors in the cardiovascular system.
@en
Beta3-adrenoceptors in the cardiovascular system.
@nl
P2093
P1476
Beta3-adrenoceptors in the cardiovascular system.
@en
P2093
Balligand JL
Gauthier C
P304
P356
10.1016/S0165-6147(00)01562-5
P577
2000-11-01T00:00:00Z